AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
ALEMV.PA

Emova Group SA (ALEMV.PA) fair value

Consumer Cyclical · Specialty Retail · Euronext Paris · France
€0.63-3.82%
Market cap €13MNext earnings 2025-01-31Updated Oct 22, 2026
Our verdict
Trades 62% below our fair value
Price
€0.63
Model fair valueConfidence: good
€1.65
Model range
€1.01 to €2.43
Fair value €1.65
Price €0.63
2 models fit Emova Group SA and they disagree: 0 of 2 land within 15% of the average. The price is below every model.
Two or more of our models back this value.
Large discount(i)Silver76
Valued as a mature, profitable company: Discounted cash flow, EV/EBITDA comparison, and Graham number.
ACCE opinionEmova Group SA (ALEMV.PA)
Fair value (2 models)
€1.65
ACCE price target
€1.00
Rating
Undervalued
Horizon
12 months
Fair value published on 22 Oct 2026, 14:04 CEST.
ACCE price target published on 23 Oct 2026, 01:53 CEST.
Rating published on 22 Oct 2026, 14:04 CEST.
Price used: €0.63 at the close on 23 Oct 2026, 17:30 CEST.
Models: Discounted cash flow and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
61.9% below
+162.5% to fair value
ACCE score
52
out of 100
P/E
7.9x
forward 0.0x
1-year return
+8.6%
Dividend yield
0.00%

Emova Group SA in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Emova Group runs a portfolio of specialty retail and franchise concepts in Spain and Portugal, and the 70.3% gross margin suggests a mix weighted toward own-brand product rather than resold merchandise. At a 13M EUR market cap, the stock is a micro-cap with no index membership, so the usual sources of demand and liquidity are absent and coverage is thin. The case for a deeper look rests on the valuation gap: a trailing P/E of 8.2 against a forward P/E of 2.6 implies earnings expected to roughly triple, which is either a sign of a sharp recovery in profitability or of forecasts that deserve skepticism. Against that, revenue growth of 0.4% and a 5.1% ROE are weak, so the thesis depends on margin recovery being real and not a forecasting artifact. This is worth a closer look at the filings and forecast assumptions, not a conclusion in either direction.

AI-assisted·How I use AIWritten Oct 23, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where ALEMV.PA's valuation models land
Price
€0.63
Model fair value
€1.65
Model range
€1.01 to €2.43
Fair value €1.65
Price €0.63
The price is below the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
Graham number
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
+0.0%
1 month
+8.6%
3 months
-22.2%
6 months
-1.6%
YTD
+10.5%
1 year
+8.6%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:53 CESTACCE price target€1.00first publication€0.66
22 Oct 2026, 14:04 CESTRatingUndervaluedfirst publication€0.65
22 Oct 2026, 14:04 CESTFair value€1.65first publication€0.65

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in EUR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full ALEMV.PA page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth19Value76Quality64Momentum47Total52
Valuation
Trailing P/E
7.9x
Forward P/E
0.0x
PEG
no data
P/B
0.41x
EV / Revenue
1.1x
Book value/sh
€2.51
Enterprise value
€30M
Profitability
ROE
5.1%
FCF yield
33.71%
ROIC
2.9%
Health and risk
Debt / equity
0.57
Dividend yield
0.00%
Beta
0.36

Price

+10.5% · 1Y

Ask anything about ALEMV.PA

Answered from Emova Group SA fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 83% of peers
low 0.0x7.9xhigh 62.5x
ROEbetter than 17% of peers
low -27%5%high 133%
Div yieldbetter than 67% of peers
low 0.0%0.0%high 3.0%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
ALEMV.PA Emova Group SA€0.63€262% below7.9x5.1%6452
PET.TO Pet Valu Holdings Ltd.C$19.85C$214% below13.8x133.3%6460
NEWA-B.ST New Wave Group AB (publ)kr 99.65kr 8124% above16.5x11.8%6362
SVV Savers Value Village Inc. Common Stock$9.37$584% above62.5x5.7%4247
FAST.AS Fastned B.V.€33.30----27.0%3449
EYE National Vision Holdings Inc. Common Stock$18.67$9101% above30.1x5.8%5643
SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.) Common Stock$17.40$2530% below9.1x23.5%6071

Sector report card

Where ALEMV.PA ranks against its sector peers on each metric.

Computing percentiles…